gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · CDXSMaterialsIndustrial Chemicals

Codexis, Inc. (CDXS)

$1.09+0.46%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$1.08▼ 52.21% in range
Nov 3, 2025Low $0.98 · High $2.85Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

Codexis closed at $1.08 on Nov 4, up 0.46%, 61.9% below its 52-week closing high. Volume of 329.5K shares was 0.37× its 20-day average (below normal).

Split-adjusted performance: -20.2% over one month, -59.2% over six months, -52.0% over one year.

In the quarter ended Jun 30, 2026, revenue was $14.91M, down 2.7% from a year earlier, with a net margin of -80.5%.

Short interest was 5.0M shares at the Oct 15 settlement, up 2.4% from the prior report (4.7% of float, 6.3 days to cover).

Market cap$118.8M109.5M shares
Revenue · quarter$14.9M−2.7% YoY
Diluted EPS$-0.13—
P/E · TTM—P/S 1.5×
Net margin-80.5%Gross 76.5%
Dividend yieldNone
52-week range0.98 – 2.85−61.9% from high
Volume329.5K0.37× 20-day avg
Volatility · 60d66.2%Annualised
Short % of float4.7%6.3 days to cover
Net cash$14.0MCash $54.9M
Next earnings—Not scheduled
Split-adjusted performance
1W −13.9%1M −20.2%3M −26.7%6M −59.2%YTD −33.4%1Y −52.0%3Y −29.5%5Y −96.8%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Industrial Chemicals

Percentile among 29 companies (100 = best)

6-month momentum19
Revenue growth13
Net margin8
Value (low P/E)—
Size21

Industry medians: 6-month return −17.9%, revenue growth +8.0%, net margin 4.8%, P/E 15.1×.

Short interest

Details →
Shares short5.0M+2.4% vs prior
Days to cover6.3Settled Oct 15
% of float4.7%
Short vol. 10d49.1%of daily volume

Closest peers by size in Industrial Chemicals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
CDXSCodexis$1.09+0.46%−59.2%−2.7%−80.5%—$118.8M
LODEComstock$1.49+6.83%−54.6%−19.7%−9335.1%—$112.8MCompare
LTBRLightbridge$4.40−7.95%−69.3%———$155.0MCompare
AMTXAemetis, Inc. (DE)$1.26+9.57%−61.1%+20.0%−14.9%—$90.9MCompare
LNZALanzaTech Global$5.24+3.05%−76.4%−0.8%2044.7%0.4$68.5MCompare
FFFuture Fuel$5.60−1.67%+16.8%+120.7%14.4%—$245.4MCompare
ALTOAlto Ingredients$3.550.00%−36.2%+12.5%4.6%5.4$275.4MCompare
GEVOGevo$1.31+9.66%−36.3%+7.1%−380.5%—$322.6MCompare
SAFXXCF Global$0.1009−4.72%−77.6%———$41.9MCompare

News about Codexis

All news →
Codexis Announces Pricing of Public Offering of Common StockGlobeNewswire Inc. · Jul 24, 2026Neutral

Quick answers

What does Codexis do?
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis.
What is CDXS's market cap?
$118.81M, based on the Nov 4 close of $1.08.
Does Codexis pay a dividend?
No regular cash dividend has been paid in the last year.
How much of CDXS is sold short?
5.0M shares, 4.7% of float, as of Oct 15, 2026.
What sector is CDXS in?
Materials, in the Industrial Chemicals industry.

About Codexis

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

HQ: Redwood City, CA146 employeesListed Apr 22, 2010codexis.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology